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Caffeic acid (CA, 3,4-dihydroxycinnamic acid), at 2% in the
diet, had been shown to be carcinogenic in forestomach and kidney
of F344 rats and B6C3F1 mice. Based on its occurrence in coffee
and numerous foods and using a linear interpolation for cancer
incidence between dose 0 and 2%, the cancer risk in humans would
be considerable. In both target organs, tumor formation was pre-
ceded by hyperplasia, which could represent the main mechanism
of carcinogenic action. The dose-response relationship for this
effect was investigated in male F344 rats after 4-week feeding with
CA at different dietary concentrations (0, 0.05, 0.14, 0.40, and
1.64%). Cells in S-phase of DNA replication were visualized by
immunohistochemical analysis of incorporated 5-bromo-2'-deoxy-
uridine (BrdU), 2 hr after intraperitoneal injection. In the fore-
stomach, both the total number of epithelial cells per millimeter
section length and the unit length labeling index of BrdU-positive
cells (ULLI) were increased, about 2.5-fold, at 0.40 and 1.64%.
The lowest concentration (0.05%) had no effect. At 0.14%, both
variables were decreased by about one-third. In the kidney, the
labeling index in proximal tubular cells also indicated a J-shaped
(or U-shaped) dose response with a 1.8-fold increase at 1.64%. In
the glandular stomach and in the liver, which are not target organs,
no dose-related effect was seen. The data show a good correlation
between the organ specificity for cancer induction and stimulation
of cell division. With respect to the dose-response relationship
and the corresponding extrapolation of the animal tumor data to
a human cancer risk, a linear extrapolation appears not to be
appropriate . © 1997 Soday of Toxicology.
Caffeic acid (3,4-dihydroxycinnamic acid; CA), a natural
phenolic antioxidant, is widely distributed in vegetables,
fruits, and beverages (Herrmann, 1989). It occurs mainly in
1
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conjugated forms. In chlorogenic acid, the most abundant
derivative, the carboxylic acid function of CA is linked with
a hydroxyl group of quinic acid.
CA, as other polyphenols, has attracted attention for hav-
ing both hazardous and beneficial effects [review (Stich,
1991)]. Administered at 2% in the diet for 2 years, CA was
shown to induce hyperplasia and tumors in the forestomach
and kidney of F344 rats and B6C3F1 mice (Hagiwara et al,
1991). When administered to male F344 rats after initiation
with 7V-methyl-W-nitro-/V-nitrosoguanidine (MNNG), 0.5%
CA in the diet for 35 weeks (Hirose et al., 1991) or 1% CA
for 51 weeks (Hirose et al, 1992) increased the incidence
of forestomach tumors observed after initiation with MNNG
alone. Treatment of female Sprague-Dawley rats with 0.5%
CA for 51 weeks after initiation with 7,12-dimethylbenz[a]-
anthracene also resulted in a higher incidence of forestomach
tumors (Hirose et al, 1988). On the other hand, CA at 0.05%
for 32 weeks inhibited the formation of squamous epithelial
carcinomas of the rat tongue induced by 4-nitroquinoline-l-
oxide given for 5 weeks (Tanaka et at, 1993) and of mouse
forestomach tumors induced by benzo(a)pyrene (at 0.54%
CA) (Wattenberg et al, 1980). Thus, CA was shown to be
carcinogenic at 2%, tumor-promoting activity was shown at
0 .5-1%, and anticarcinogenic effects at 0.05-0.5%.
Exposure of humans to CA strongly depends on the coffee
consumption. Moderately high consumers may ingest about
9 mg/kg body wt per day. The intake from foods, mainly
from tomatoes and potatoes, was estimated to be about 0.2
mg/kg body wt per day (National Research Council, 1996).
The human cancer risk, linearly extrapolated from the animal
tumor data to a dose of 1 mg/kg body wt per day would
result in a value as high as 1 in 1000 lives (Lutz and Schlat-
ter, 1992). A linear extrapolation to the human exposure
level might be appropriate for DNA-reactive carcinogens.
For CA, this mechanism of action is unlikely. CA showed
no mutagenic effects in different bacterial test systems. On
the other hand, forward mutations were induced in cultured
mouse lymphoma L5178Y cells, and chromosomal aberra-
tions were induced in cultured Chinese hamster ovary cells
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(Hanham et al, 1983). In the IARC monograph on CA it
was concluded that indirect genotoxicity via reactive oxygen
species or tumor-promoting activity, possibly based on the
stimulation of cell division, might be more relevant than
DNA reactivity (IARC, 1993). For this mechanism of action,
nonlinear dose-response relationships are more widely ac-
cepted. Therefore, the dose-response relationship for the
stimulation of cell proliferation by CA in target and nontar-
get organs of the rat was investigated.
MATERIALS AND METHODS
Pilot Study (BrdU Mimpump for 24 hr)
Animals and diet. Diets were prepared by mechanical dry mixing for
1 hr of powder maintenance diet No. 890 from Nafag AG, Gossau SG,
Switzerland, with caffeic acid (Fluka; 97% pure). Fifteen 8- to 10-week-
old male F344 rats from Charles River, Savo GmbH, Kisslegg, Germany,
were housed 5 to a plastic cage with hardwood chips for bedding and
acclimatized for 1 week with a 12-hr light-dark cycle, control diet and tap
water ad libitum.
Treatments. Animals were randomized by body weight into three
groups of five and received a diet containing 0, 0.2, or 2% caffeic acid
(nominal concentrations) for 4 weeks. Body weight and food consumption
were measured twice weekly. At the end of the treatment, osmotic mini-
pumps (Alzet 2001 D, 8 ^1/hr, Alza Corp., Palo Alto, CA) filled with 220
fi\ of a solution of 5-bromo-2'-deoxyuridine (BrdU, Sigma) [20 mg BrdU
per milliliter, 10 mM potassium phosphate, 130 mM NaCl, pH 7.6 (PBS);
plus 1% 1 N NaOH] were surgically implanted sc over the dorsal thoraco-
lumbar area under ether anesthesia. Incisions were closed with surgical
clips. Twenty-four hours later the animals were killed following ether anes-
thesia, and the stomach and the first part of the small intestine were removed.
Other procedures. See "Main Study."
Main Study (BrdU ip for 2 hr)
Diet. Powder maintenance diet Altromin 1324 (Altromin, Lage, Ger-
many) was mixed with caffeic acid (Fluka; 97% pure) to give nominal
concentrations of 0, 0.066, 0.2, 0.66, and 2% and pelleted without steam.
The diet was prepared once and kept at room temperature. The concentration
of caffeic acid in the diets was measured after extraction with methanol by
RP-HPLC with UV detection (column: Partisil ODS-3, 5 jim, 250 X 4 mm;
solvent A: H2O/trifluoroacetic acid, pH 2.0; solvent B: methanol; gradient:
0-100% B in 30 min; flow rate: 1 ml/min; detection wavelength: 320 nm).
Based on a standard curve, the concentrations in the diets (weight per
weight) were 0, 0.05 (76% of nominal), 0.14 (70%), 0.40 (61 %), and 1.64%
(82%). There was no indication of loss of CA during storage of the diet,
as indicated by reanalysis of the 0.2% (nominal) diet after the 4-week
treatment period (0.14% measured).
Animals and treatments. Twenty-five 10-week-old male F344 rats from
H. Winkelmann (Borchen, Germany) were used. To synchronize the animals
with respect to a diurnal cycle of cell proliferation, a well-known phenome-
non in the liver which can result in large interindividual variability (Bursch
and Schulte-Hermann, 1983), food was available only during the dark phase.
The animals were randomized by body weight (210-237 g) into five groups
of five animals each and given a diet containing caffeic acid at four dose
levels for 4 weeks. Food consumption per cage (five animals) was measured
daily and body weight twice weekly. After 4 weeks, the rats were injected
ip with BrdU (Sigma, 6 mg/ml PBS; 0.5 ml/100 g body wt). After 2 hr the
animals were killed under ether anesthesia.
Stomach, liver, the left kidney, and the second centimeter of the duode-
num were removed. The stomach was opened along the greater curvature,
rinsed with PBS before weighing, and pinned flat on a cork board. Tissues
were fixed in 4% neutral buffered formalin for at least 48 hr. A 3-mm-
wide strip was cut parallel to the lesser curvature of the stomach (including
the forestomach). Sections of 2 -4 mm of the left hepatic lobe and longitudi-
nal sections of the left kidney were made.
The tissue specimens were dehydrated and embedded in paraffin, cut
into 2-/xm sections, and mounted on 3-aminopropyltriethyloxysilane-coated
slides to ensure adhesion during processing. Tissue sections were stained
either with hematoxylin/eosin or immunohistochemically for BrdU.
lmmunohistochemistry for BrdU. The sections were stained immuno-
histochemically for the incorporation of BrdU into DNA (Dietrich and
Swenberg, 1991). Briefly, tissue sections were incubated with a murine
monoclonal antibody to BrdU (Biogenex, San Ramon, CA), diluted 1:200,
followed by biotinylated goat anti-mouse IgG (rat-adsorbed) and alkaline
phosphatase-conjugated streptavidin (Super Sensitive Ready-to-Use Animal
Detection Kit, Biogenex). The endogenous alkaline phosphatase activity
was blocked by 5 mM levamisole (Sigma). Fast red (Biogenex) was used
as chromagen and hematoxylin as counterstain.
The small intestine, an organ with a high cell proliferation rate, served
as positive control for the BrdU systemic availability and staining. For
negative controls, the primary anti-BrdU antibody was omitted.
Scoring and statistics. Tissue sections were examined microscopically
for BrdU-labeled nuclei ("red cells") and unlabeled nuclei ("blue cells").
In the forestomach, the epithelium (i.e., the layer limited by the arrows
shown in Fig. 2) was examined over a section length of 4 mm Muscularis
mucosae proximal to the limiting ridge. The total number of counted cells,
i.e., the sum of "red" and "blue," was between 800 (at 0.14% CA; epithe-
lial thinning observed) and 6200 (at 1.64% CA; in the animal which showed
the most severe hyperplasia). The counts were expressed as (i) total cells
per millimeter and (ii) red cells per millimeter. The latter value is equivalent
to the labeling index ULLI as defined by Monticello et al. (Monticello et
al., 1990). Red nuclei were present uniquely in the basal cell layer of the
epithelium.
In the glandular stomach, the total area of five randomly selected 0.25
x 0.25-mm fields per section was scored, placing the area of replication in
the center (these fields did not cover the entire thickness of the epithelium).
This resulted in a count of about 2000 cells per section. The data were
expressed as stated for the forestomach.
For liver and kidney, a labeling index LI was defined as the ratio "red
divided by red plus blue." In the liver, an entire section (80-150 mm2)
was evaluated for labeled hepatocytes. The resulting number was divided
by the total number of hepatocytes (on average 1500/mm2).
In the kidney, the anatomic analysis followed described procedures (Lar-
son et al., 1994). As many fields as necessary to score at least 60 labeled
proximal tubular cells in the cortex were evaluated so that the binomial
variation was not larger than the overall animal to animal variability. For
the number of total proximal tubular cells per field, at least 4000 proximal
tubular cells were scored in 10 randomly selected fields.
Student's t test (two-tail) was used to test for the significance of a differ-
ence between the dose groups.
RESULTS
Pilot Study
Food consumption and body weight. The animals given
CA in the diet showed no difference in food intake or body
weight gain compared to the controls. On a 4-week average,
the rats consumed 18.6-19.3 g/day and the average (nomi-
nal) intakes of caffeic acid were 136 and 1386 mg/kg body
wt per day for the 0.2 and 2% CA groups, respectively.
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FIG. 1. Forestomach: Number of total epithelial cells per millimeter
section length (A) and unit length labeling index (ULLI, number of BrdU-
positive cells per millimeter section length) (B) in the forestomach of male
F344 rats, after 4 weeks of feeding with caffeic acid at different dietary
concentrations. O, individual animals; +, mean value (n = 5). Pilot study:
BrdU was administered via sc implanted osmotic pump for 24 hr. p <
0.0001 for 0 vs 2% CA (A and B; Student's t test).
Cell proliferation. The number of total cells/mm and the
"unit length labeling index" ULLI in the forestomach are
shown in Figs. 1A and IB. Treatment with 0.2% CA had
no effect. At 2% CA, the ULLI and the number of total
cells/mm were significantly increased by factors of 6- and
8-fold, respectively.
When analyzed in terms of the labeling index LI, values
of 36.0, 37.9, and 48.5% were derived for the 0, 0.2, and
2% CA groups, respectively. The high value in the control
group indicates that the availability of BrdU for as long
as 24 hr allowed a large fraction of the epithelial cells to
incorporate BrdU, so that little space for the detection of a
treatment-related increase was left. This was accounted for
under the experimental conditions chosen for the main study.
Main Study
For the main study, BrdU pulse labeling was used, with
sacrifice 2 hr after ip injection. A larger number of dose
groups was included, to cover the entire dose range observed
for carcinogenic, tumor-promoting, and anticarcinogenic ef-
fects of CA. In addition, the kidney, another target organ
for tumor induction, as well as liver and glandular stomach,
two nontarget organs, was investigated.
Food consumption and body weight. The animals given
CA in the diet showed no difference in food consumption
or body weight gain compared to the controls. They con-
sumed the same amount of food as in the pilot study. The
doses of CA were 35, 100,269, and 1147 mg/kg body wt per
day for the 0.05, 0.14, 0.4, and 1.64% groups, respectively.
Pathology. Macroscopically, the forestomach of three
rats given 1.64% CA and two rats given 0.4% CA showed
coating with a grey-white material. In the 1.64% CA group,
the forestomach of one rat was covered with striped hemor-
rhage; one rat showed one point hemorrhage. The fore-
stomach of the rats given 0.14% CA appeared thinner and
was difficult to section. No gross pathological alterations
were seen in the forestomach of the remaining animals.
Microscopically, 1.64% CA induced severe hyperplasia
of the epithelium (>0.5 mm thickness) and hyperkeratosis
in the forestomach of one rat, moderate hyperplasia (0.1 —
0.5 mm) in two, mild (<0.1 mm) in one, and none in one rat.
There was a pronounced difference between the individual
animals in this dose group. In the 0.4% CA group, moderate
hyperplasia and hyperkeratosis were observed in all animals
(Fig. 2C). In the 0.14% CA group, the macroscopic observa-
tion of a thinner forestomach wall (in relation to the controls)
was confirmed in all animals (Fig. 2B). There was no histo-
pathological alteration in the 0.05% CA group or in the
control group (Fig. 2A).
In glandular stomach, liver, and kidney, no histopathologi-
cal changes were observed.
Cell proliferation. One rat in the control group did not
show detectable BrdU labeling in any organ; the reason is
unknown. This animal was excluded. In the forestomach,
the total number of cells/mm and the ULLI as a function of
dose are shown in Figs. 3A and 3B, respectively. The lowest
dose group (0.05% CA) was not different from control. The
0.14% CA group showed a decrease of about a third in both
total cells/mm (/? < 0.0006) and the ULLI (p < 0.06). This
finding is in agreement with the microscopic observation of
a thin lining. The group given 0.4% CA showed a 2.5-fold
increase and both values, labeled and total cell numbers per
millimeter, were significantly different from controls. In the
highest dose group (1.64% CA) the interindividual differ-
ence was very large. The values obtained for the individual
rats paralleled the microscopic observations in that the top
cell number was seen in the animal with the most severe
hyperplasia. Compared with the second highest dose group,
no further increase was achieved on average. The biological
response appeared to be saturated at 0.4% CA already.
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fA In the glandular stomach (Figs. 4A and 4B), no CA dose-related effects were seen. This is in agreement with the
fact that the glandular stomach is not a target organ for
tumorigenicity of CA. The same holds for the liver where
the data are expressed as labeling indices for hepatocytes
(Fig. 5). The LI in the control group was 0.29 ± 0.12 (n =
4). Labeled hepatocytes were evenly distributed over the
entire section without zonal differences.
The LI in the proximal tubules of the kidney was 0.18
± 0.03 (n = 4) for controls. It was significantly increased
by a factor of 1.8 in the highest dose group (Fig. 6). A
numerical increase was seen in the second highest dose,
while 0.14% CA had no effect. The decrease seen at 0.05%
was borderline significant (p = 0.085 for the two-tailed
Student t test).
FIG. 2. Forestomach: Histologies] observations in the forestomach of
male F344 rats, after 4 weeks of feeding with caffeic acid in the diet at 0
(A, control), 0.14% (B, thinning), and 0.4% (C, moderate hyperplasia). The
epithelial layer is marked by arrows.
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FIG. 3. Forestomach: Number of total epithelial cells per millimeter
section length (A) and unit length labeling index (ULLI, number of BrdU-
positive cells per millimeter section length) (B) in the forestomach of male
F344 rats, after 4 weeks of feeding with caffeic acid at different dietary
concentrations. O, individual animals; +, mean value [n = 5 (4 in control
group)]. BrdU was administered via ip injection 2 hr before killing. Stu-
dent's t test (two-tailed): 0 vs 0.4% CA, p < 0.0001 for A and p < 0.003
for B (increase); 0 vs 0.14% CA, p < 0.0006 for A and p < 0.06 for B
(decrease).
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FIG. 4. Glandular stomach: Number of cells per millimeter section
length (A) and unit length labeling index (ULLI, number of BrdU-positive
cells per millimeter section length) (B) in the glandular stomach of male
F344 rats, after 4 weeks of feeding with caffeic acid at different dietary
concentrations. O, individual animals; +, mean value [n = 5 (4 in control
group)]. BrdU was administered via ip injection 2 hr before killing.
DISCUSSION
The stimulation of cell proliferation has become a widely
accepted intermediate endpoint for nongenotoxic carcino-
genesis(Butterworthefa/., 1991, 1992; Clayson etal., 1991;
Cohen et al., 1991; Jones et al., 1996; Monticello et al.,
1996). Dividing cells are "cells at risk," due to a higher
probability to accumulate mutations from primary DNA le-
sions and to loose heterozygosity for tumor suppressor genes
by mitotic recombination. The perfect concordance shown
here between target organs for tumor induction and target
organs for increased number of cell divisions indicates that
this mechanism of action may contribute to the tumorigenic-
ity of caffeic acid.
In the forestomach, Kagawa et al. (Kagawa et al., 1993)
and Ito et al. (Ito et al., 1993) noted increased cell prolifera-
tion, elevated DNA synthesis, and hyperplasia to parallel
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FIG. 5. Liver BrdU labeling index in the liver of male F344 rats, after
4 weeks of feeding with caffeic acid at different dietary concentrations. O,
individual animals; +, mean value [n = 5 (4 in control group)]. BrdU was
administered via ip injection 2 hr before killing.
carcinogenesis by CA. The authors concluded that CA acted
primarily as mitogen, with regeneration due to toxicity fur-
ther enhancing cell proliferation (Ito et al., 1993). In the
present study, 4-week exposure resulted in an increase of
both the total number of cells per millimeter section length
and the number of S-phase cells only at the highest two dose
levels (0.4 and 1.64%). The cell proliferation data were fully
supported by the histopathological findings of severe or mod-
erate hyperplasia and hyperkeratosis. While the lowest dose
(0.05% CA) produced no effect at all, the data seen at 0.14%
were unexpected. The number of both total cells and S-phase
cells was decreased, compared to the controls. This was
Kidney
Caffeic acid In diet (%)
FIG. 6. Kidney: BrdU labeling index in proximal tubular cells in the
kidney of male F344 rats, after 4 weeks of feeding with caffeic acid at
different dietary concentrations. O, individual animals; +, mean value [n
= 5 (4 in control group)]. BrdU was administered via ip injection 2 hr
before killing, p < 0.0004 for 0 vs 1.64% CA (increase); p = 0.085 for 0
vs 0.05% CA (decrease; two-tailed Student's / test).
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paralleled by the observation of extremely thin forestomach
tissue layers. This low-dose phenomenon of delayed cell
division could also explain some of the cancer-protective
effects described in the Introduction.
In the kidney, the other target organ of CA-induced carci-
nogenesis in the rat (Hagiwara et al., 1991), the labeling
index for cells of the proximal tubules was increased only
at the highest dose level. As seen in the forestomach, the
dose-response curve showed a J shape. However, the de-
crease at low dose was only borderline significant. In the
glandular stomach and in the liver, no CA-induced effects
were detected.
The measures of cell division in the control animals were
in perfect agreement with the recently published values for
various cancer target tissues of male and female F344 rats
and B6C3F1 mice (Eldridge and Goldsworthy, 1996). Label-
ing indices LI of 0.23 and 0.17 in male F344 rat liver and
kidney, respectively, and a ULLI value of 35 ± 12 in the
forestomach were reported for an age range of 7 to 20 weeks.
The determination of S-phase cells by immunohistochemical
labeling after a 2-hr BrdU pulse appears to show little vari-
ability between laboratories, if performed under identical
conditions. In addition to methodical feasibility, the data
show a good correlation between those organs that show
sustained stimulated cell division at subchronic treatment
and susceptibility with respect to tumor development in long-
term studies.
Human exposure to CA occurs predominantly as chlo-
rogenic acid, an ester formed between CA and a hydroxyl
group of quinic acid (Herrmann, 1989). In a 4-week feeding
study with 2% chlorogenic acid, no effect on the rat foresto-
mach was observed (Hirose et al., 1987), while CA tested
in parallel produced pronounced hyperplasia throughout the
forestomach epithelium.
Humans have no forestomach. For a cancer risk assess-
ment, the situation in the kidney might be more relevant. The
question to what extent CA from chlorogenic acid becomes
available systemically has been addressed in the rat and in
humans. After oral administration, no chlorogenic acid was
detectable in urine (Booth et al, 1957). Therefore, the fol-
lowing risk assessment is based on the worst-case assump-
tion that all CA ingested as chlorogenic acid becomes avail-
able systemically.
In the carcinogenicity study with 2% CA (Hagiwara et al.,
1991), the induction of tubular cell adenoma in the kidney of
male rats (4/30) and female mice (8/30) was strongly corre-
lated with tubular cell hyperplasia (21/30 and 28/30, respec-
tively). If hyperplasia is the dominant factor in the process of
kidney tumor induction, only doses that result in a sustained
increase of cell division would constitute a cancer risk. In
the present study, the lowest dietary concentration that pro-
duced a slight increase in the labeling index was 0.4%, which
was equivalent to a dose of 270 mg/kg body wt per day.
The decrease of the labeling index responsible for the J shape
of the dose-response curve was observed at 0.05% (35 mg/
kg body wt per day). Therefore, even for strong coffee drink-
ers who might ingest up to 10 mg CA/kg body wt per day
(predominantly in the form of chlorogenic acid), the expo-
sure would be in the range of potential protection rather than
potential harm, in terms of the effects on the rate of cell
division, and under the assumption that the data can be ex-
trapolated from rat to human.
On the basis of all data combined it is concluded that the
cancer risk for humans associated with the dietary intake of
caffeic acid might be negligible.
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